Weight-Loss Drug Linked to Lower Risk of Eye Disease in Patients with Diabetes | Newsroom
The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a...
The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a...
image: Dr. Szilárd Kiss view more Credit: Weill Cornell Medicine The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro...
For the founder of Visionary Eye, Dr. Shehz Batliwala, restoring vision is more than a medical outcome; it is a...
Study design A cross-sectional study was conducted among patients with diabetes attending the outpatient unit of the Endocrinology Department at...
Findings to be presented at the American Heart Association Scientific Sessions 2025 in New Orleans suggest that combining healthy lifestyle...
AMA News Wire What doctors wish patients knew about improving eye health May 29, 2025 Good vision is essential for...
NYC Health + Hospitals’ Lifestyle Medicine Program Held Over 10,000 Group Visits and Served More Than 1,300 Patients in...
Oral infections carry high risks for people with sickle cell disease (SCD), but most young patients who have insurance through...
UW School of Medicine researchers have created the Health Octo Tool, a holistic assessment using individuals’ health exams and lab...